Regulation of programmed death ligand 1 (PD‐L1) expression by TNF‐related apoptosis‐inducing ligand (TRAIL) in triple‐negative breast cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Regulation of programmed death ligand 1 (PD‐L1) expression by TNF‐related apoptosis‐inducing ligand (TRAIL) in triple‐negative breast cancer cells

Published:2022-10-14 Issue:2 Volume:62 Page:135-144
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Molecular Carcinogenesis

Author:

Pimentel Julio M.¹²³^ORCID,Zhou Jun‐Ying¹³,Wu Gen Sheng¹²³⁴

Affiliation:

1. Molecular Therapeutics Program, Karmanos Cancer Institute Wayne State University School of Medicine Detroit Michigan USA

2. Cancer Biology Program Wayne State University School of Medicine Detroit Michigan USA

3. Department of Oncology Wayne State University School of Medicine Detroit Michigan USA

4. Department of Pathology Wayne State University School of Medicine Detroit Michigan USA

Funder

National Institutes of Health

Wayne State University

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.23471

Reference50 articles.

1. Cancer statistics, 2022

2. Adjuvant therapy of triple negative breast cancer

3. Triple negative breast cancer: current understanding of biology and treatment options

4. Triple-Negative Breast Cancer

5. Efficacy and Economics of Hormonal Therapies for Advanced Breast Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Death Receptor 5 (DR5) for imaging and treatment of primary bone and soft tissue tumors: an update of the literature;Frontiers in Molecular Biosciences;2024-09-02

2. TRIAL-based combination therapies in cancers;International Immunopharmacology;2024-09

3. Immune Modulation of Innate and Adaptive Responses Restores Immune Surveillance and Establishes Antitumor Immunologic Memory;Cancer Immunology Research;2023-12-29

4. Immune modulation of innate and adaptive responses restores immune surveillance and establishes anti-tumor immunological memory;2023-09-29

5. Dose-related immunomodulatory effects of recombinant TRAIL in the tumor immune microenvironment;Journal of Experimental & Clinical Cancer Research;2023-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3